ARS Pharmaceuticals, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1291668,
    "name": "ARS Pharmaceuticals, Inc.",
    "stock_name": "ARS Pharmaceuticals, Inc.",
    "full_name": "ARS Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/ars-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "9.97",
    "chg": 0.93,
    "chgp": "10.29%",
    "dir": 1,
    "prev_price": "9.04",
    "mcapval": "1,057.44",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US82835W1080",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "935.94 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ars-pharmaceuticals-inc-1291668-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ARS Pharmaceuticals Hits Day High with 7.99% Surge to $8.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-day-high-with-799-surge-to-885-3686600",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ARSPharmaceutic_priceRelatedfactors_3686600.png",
        "date": "2025-11-10 17:57:49",
        "description": "ARS Pharmaceuticals, Inc. saw a notable increase in its stock today, reaching an intraday high. Despite this uptick, the company has faced significant challenges over the past year, including substantial declines in performance metrics and rising raw material costs, contributing to ongoing financial difficulties."
      },
      {
        "title": "ARS Pharmaceuticals Hits New 52-Week Low at $8.05 Amid Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-new-52-week-low-at-805-amid-declining-performance-3686516",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ARSPharmaceutic_priceRelatedfactors_3686516.png",
        "date": "2025-11-10 17:29:25",
        "description": "ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported negative financial results after a series of positive quarters, with troubling metrics such as a return on equity of -24.97% and substantial operating losses."
      },
      {
        "title": "ARS Pharmaceuticals Hits New 52-Week Low at $8.14 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-new-52-week-low-at-814-amid-financial-struggles-3680214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ARSPharmaceutic_priceRelatedfactors_3680214.png",
        "date": "2025-11-07 16:15:24",
        "description": "ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including a negative return on equity and rising raw material costs, while its recent operating profit has also decreased substantially."
      },
      {
        "title": "ARS Pharmaceuticals Hits New 52-Week Low at $8.33",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-new-52-week-low-at-833-3671553",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ARSPharmaceutic_priceRelatedfactors_3671553.png",
        "date": "2025-11-04 18:08:54",
        "description": "ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a challenging financial landscape marked by a significant operating loss and rising raw material costs. The company faces negative return on equity and a high price-to-book ratio, indicating struggles in maintaining profitability compared to broader market performance."
      },
      {
        "title": "ARS Pharmaceuticals Hits New 52-Week Low at $8.45 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-new-52-week-low-at-845-amid-financial-struggles-3667354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ARSPharmaceutic_priceRelatedfactors_3667354.png",
        "date": "2025-11-03 17:20:13",
        "description": "ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including a negative return on equity and substantial operating losses, amid rising raw material costs and a high price-to-book ratio."
      },
      {
        "title": "ARS Pharmaceuticals Hits New 52-Week Low at $8.59 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-new-52-week-low-at-859-amid-financial-struggles-3662054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ARSPharmaceutic_priceRelatedfactors_3662054.png",
        "date": "2025-10-31 16:33:14",
        "description": "ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported negative financial results after a series of positive quarters, with key metrics indicating ongoing challenges, including a negative return on equity and substantial operating losses."
      },
      {
        "title": "ARS Pharmaceuticals Hits New 52-Week Low at $8.90 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-new-52-week-low-at-890-amid-financial-struggles-3659223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ARSPharmaceutic_priceRelatedfactors_3659223.png",
        "date": "2025-10-30 18:56:29",
        "description": "ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 1,057 million, is currently operating at a loss, facing rising raw material costs and negative financial metrics amid a challenging market environment."
      },
      {
        "title": "ARS Pharmaceuticals Hits New 52-Week Low at $9.08 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-new-52-week-low-at-908-amid-financial-struggles-3649318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ARSPharmaceutic_priceRelatedfactors_3649318.png",
        "date": "2025-10-27 17:06:39",
        "description": "ARS Pharmaceuticals, Inc. has reached a new 52-week low, trading at USD 9.08 on October 24, 2025. The company has faced financial challenges, including a negative return on equity and significant operating losses. Its stock has underperformed compared to broader market indices, raising concerns among stakeholders."
      },
      {
        "title": "ARS Pharmaceuticals Hits Day High with 7.55% Surge to $11.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ars-pharmaceuticals-hits-day-high-with-755-surge-to-1111-3608186",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ARSPharmaceutic_priceRelatedfactors_3608186.png",
        "date": "2025-10-09 21:06:17",
        "description": "ARS Pharmaceuticals, Inc. has seen a significant intraday stock increase, contrasting with a slight decline in the S&P 500. While the company has shown short-term gains, it faces long-term challenges, including a notable decline over the past year and rising raw material costs, impacting its financial health."
      }
    ],
    "total": 23,
    "sid": "1291668",
    "stock_news_url": "https://www.marketsmojo.com/news/ars-pharmaceuticals-inc-1291668"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

ARS Pharmaceuticals Hits Day High with 7.99% Surge to $8.85

2025-11-10 17:57:49

ARS Pharmaceuticals, Inc. saw a notable increase in its stock today, reaching an intraday high. Despite this uptick, the company has faced significant challenges over the past year, including substantial declines in performance metrics and rising raw material costs, contributing to ongoing financial difficulties.

ARS Pharmaceuticals Hits New 52-Week Low at $8.05 Amid Declining Performance

2025-11-10 17:29:25

ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported negative financial results after a series of positive quarters, with troubling metrics such as a return on equity of -24.97% and substantial operating losses.

ARS Pharmaceuticals Hits New 52-Week Low at $8.14 Amid Financial Struggles

2025-11-07 16:15:24

ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including a negative return on equity and rising raw material costs, while its recent operating profit has also decreased substantially.

ARS Pharmaceuticals Hits New 52-Week Low at $8.33

2025-11-04 18:08:54

ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a challenging financial landscape marked by a significant operating loss and rising raw material costs. The company faces negative return on equity and a high price-to-book ratio, indicating struggles in maintaining profitability compared to broader market performance.

ARS Pharmaceuticals Hits New 52-Week Low at $8.45 Amid Financial Struggles

2025-11-03 17:20:13

ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including a negative return on equity and substantial operating losses, amid rising raw material costs and a high price-to-book ratio.

ARS Pharmaceuticals Hits New 52-Week Low at $8.59 Amid Financial Struggles

2025-10-31 16:33:14

ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported negative financial results after a series of positive quarters, with key metrics indicating ongoing challenges, including a negative return on equity and substantial operating losses.

ARS Pharmaceuticals Hits New 52-Week Low at $8.90 Amid Financial Struggles

2025-10-30 18:56:29

ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 1,057 million, is currently operating at a loss, facing rising raw material costs and negative financial metrics amid a challenging market environment.

ARS Pharmaceuticals Hits New 52-Week Low at $9.08 Amid Financial Struggles

2025-10-27 17:06:39

ARS Pharmaceuticals, Inc. has reached a new 52-week low, trading at USD 9.08 on October 24, 2025. The company has faced financial challenges, including a negative return on equity and significant operating losses. Its stock has underperformed compared to broader market indices, raising concerns among stakeholders.

ARS Pharmaceuticals Hits Day High with 7.55% Surge to $11.11

2025-10-09 21:06:17

ARS Pharmaceuticals, Inc. has seen a significant intraday stock increase, contrasting with a slight decline in the S&P 500. While the company has shown short-term gains, it faces long-term challenges, including a notable decline over the past year and rising raw material costs, impacting its financial health.

View All News